VG Life Sciences Competitors and Similar CompaniesClear all
Outlook Therapeutics's competitors and similar companies include Oncolytics Biotech.
 Outlook Therapeutics Outlook Therapeutics (formerly Oncobiologics) is a clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics. |  Oncolytics Biotech Oncolytics Biotech is a company developing Pelareorep, an intravenously delivered immuno-oncolytic virus, used for the treatment of solid tumors and hematological malignancies. | |
Founding Date | Founding Date 2011 | Founding Date 1998 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Woodbridge Township, US HQ | Locations Calgary, CA HQ Calgary, CA San Diego, US |
Employees | Employees 1726% decrease | Employees 28 |
Valuation ($) | Valuation ($) 136.5 m | Valuation ($) 93.9 m |
Financial | ||
Revenue (est.) | Revenue (est.) $1.4m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $1.4m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $57.2k (FY, 2025) | Gross profit N/A |
Net income | Net income ($62.4m) (FY, 2025) | Net income ($28.8m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Oncolytics Biotech
HQ
Calgary, CA
Employees
28
Oncolytics Biotech is a company developing Pelareorep, an intravenously delivered immuno-oncolytic virus, used for the treatment of solid tumors and hematological malignancies.
View company